AFFLUENT MEDICAL |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.66 EUR | +1.53% |
|
+1.53% | -10.03% |
| 18/06 | Affluent Medical: activation of a 2nd Artus device | CF |
| 25/04 | Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 58.07 | 58.07 | - |
| Enterprise Value (EV) 2 | 62.92 | 78.74 | 107.3 |
| P/E ratio | -3.42 x | -3.06 x | -1.87 x |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | -4.52 x | -5.16 x | -3.95 x |
| EV / FCF | -5.02 x | -4.62 x | -3.75 x |
| FCF Yield | -19.9% | -21.6% | -26.7% |
| Price to Book | 1.72 x | 3.48 x | - |
| Nbr of stocks (in thousands) | 33,145 | 33,145 | - |
| Reference price 3 | 1.635 | 1.635 | 1.635 |
| Announcement Date | 25/04/24 | - | - |
1EUR in Million2USD in Million3EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | - | - | - | - |
| EBITDA 1 | - | -13.91 | -15.26 | -27.17 |
| EBIT 1 | - | -16.49 | -18.69 | -30.35 |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) 1 | -16.79 | -16.93 | -18.15 | -39.71 |
| Net income 1 | -16.61 | -16.77 | -19.62 | -31.28 |
| Net margin | - | - | - | - |
| EPS 2 | - | -0.5400 | -0.5350 | -0.8750 |
| Free Cash Flow 1 | - | -13.69 | -17.04 | -28.6 |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 30/03/23 | 25/04/24 | - | - |
1USD in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt 1 | - | 10.7 | 20.7 | 49.2 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.8213 x | -1.355 x | -1.812 x |
| Free Cash Flow 1 | - | -13.7 | -17 | -28.6 |
| ROE (net income / shareholders' equity) | - | -46.7% | -106% | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 2 | - | 0.9500 | 0.4700 | - |
| Cash Flow per Share 2 | - | -0.5500 | -0.6400 | -1.200 |
| Capex 1 | - | 0.07 | 0.82 | 1.07 |
| Capex / Sales | - | - | - | - |
| Announcement Date | 30/03/23 | 25/04/24 | - | - |
1USD in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.635
EUR
Average target price
3.367
EUR
Spread / Average Target
+105.91%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.03% | 5.81Cr | |
| +75.69% | 1.26TCr | |
| +11.65% | 692.18Cr | |
| -28.92% | 680.13Cr | |
| +9.77% | 532.28Cr | |
| -20.60% | 463.49Cr | |
| +13.02% | 394.03Cr | |
| -29.88% | 268.37Cr | |
| +27.29% | 206.34Cr | |
| -1.86% | 201.18Cr |
- Stock Market
- Equities
- AFME Stock
- Financials Affluent Medical
